Myriad Genetics: Disparities Indicated Non-Genesight Control Group Was Not Viable Control for Part Two of Study of Genesight Testing - SEC Filing
萬基遺傳:SEC文件顯示,差異表明非Genesight對照組不適合作爲Genesight測試研究的第二部分的對照組。
Myriad Genetics: Disparities Indicated Non-Genesight Control Group Was Not Viable Control for Part Two of Study of Genesight Testing - SEC Filing
萬基遺傳:SEC文件顯示,差異表明非Genesight對照組不適合作爲Genesight測試研究的第二部分的對照組。
譯文內容由第三人軟體翻譯。